Andres Y. Maldonado
Stock Analyst at H.C. Wainwright
(4.94)
# 157
Out of 4,520 analysts
301
Total ratings
57.8%
Success rate
43.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Y. Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals | Reiterated: Buy | $40 | $22.80 | +75.44% | 11 | Jul 15, 2026 | |
| ERAS Erasca | Maintained: Buy | $20 | $19.17 | +4.33% | 20 | Jul 14, 2026 | |
| IMNM Immunome | Reiterated: Buy | $40 | $22.32 | +79.21% | 6 | Jul 9, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $105 | $111.12 | -5.51% | 10 | Jun 29, 2026 | |
| VSTM Verastem | Maintained: Buy | $18 | $6.03 | +198.51% | 8 | Jun 24, 2026 | |
| RLMD Relmada Therapeutics | Reiterated: Buy | $12 | $5.24 | +129.01% | 2 | Jun 23, 2026 | |
| TCRX TScan Therapeutics | Reiterated: Buy | $7 | $0.9148 | +665.19% | 10 | Jun 23, 2026 | |
| ENGN enGene Therapeutics | Maintained: Buy | $6 → $4 | $1.82 | +119.78% | 13 | Jun 16, 2026 | |
| CRBP Corbus Pharmaceuticals Holdings | Reiterated: Buy | $40 | $9.01 | +343.95% | 17 | Jun 2, 2026 | |
| IBRX ImmunityBio | Reiterated: Buy | $15 | $7.68 | +95.31% | 25 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 | $10.18 | +125.93% | 12 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $23.57 | +112.13% | 11 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 | $1.78 | +405.62% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $5.11 | +95.69% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 | $6.99 | +243.35% | 8 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $27 | $4.10 | +558.54% | 16 | May 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $71.85 | +39.18% | 25 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $10.64 | +87.97% | 6 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $58 → $65 | $52.86 | +22.97% | 30 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 | $5.19 | +150.48% | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $4 | $0.368 | +986.96% | 27 | Dec 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $5.38 | n/a | 11 | Nov 11, 2024 |
Syndax Pharmaceuticals
Jul 15, 2026
Reiterated: Buy
Price Target: $40
Current: $22.80
Upside: +75.44%
Erasca
Jul 14, 2026
Maintained: Buy
Price Target: $20
Current: $19.17
Upside: +4.33%
Immunome
Jul 9, 2026
Reiterated: Buy
Price Target: $40
Current: $22.32
Upside: +79.21%
Monopar Therapeutics
Jun 29, 2026
Reiterated: Buy
Price Target: $105
Current: $111.12
Upside: -5.51%
Verastem
Jun 24, 2026
Maintained: Buy
Price Target: $18
Current: $6.03
Upside: +198.51%
Relmada Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $12
Current: $5.24
Upside: +129.01%
TScan Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $7
Current: $0.9148
Upside: +665.19%
enGene Therapeutics
Jun 16, 2026
Maintained: Buy
Price Target: $6 → $4
Current: $1.82
Upside: +119.78%
Corbus Pharmaceuticals Holdings
Jun 2, 2026
Reiterated: Buy
Price Target: $40
Current: $9.01
Upside: +343.95%
ImmunityBio
Jun 2, 2026
Reiterated: Buy
Price Target: $15
Current: $7.68
Upside: +95.31%
Jun 2, 2026
Maintained: Buy
Price Target: $23
Current: $10.18
Upside: +125.93%
May 26, 2026
Maintained: Buy
Price Target: $50
Current: $23.57
Upside: +112.13%
May 26, 2026
Maintained: Buy
Price Target: $9
Current: $1.78
Upside: +405.62%
May 26, 2026
Maintained: Buy
Price Target: $10
Current: $5.11
Upside: +95.69%
May 26, 2026
Maintained: Buy
Price Target: $24
Current: $6.99
Upside: +243.35%
May 20, 2026
Reiterated: Buy
Price Target: $27
Current: $4.10
Upside: +558.54%
May 18, 2026
Maintained: Buy
Price Target: $100
Current: $71.85
Upside: +39.18%
May 15, 2026
Reiterated: Buy
Price Target: $20
Current: $10.64
Upside: +87.97%
May 8, 2026
Reiterated: Buy
Price Target: $58 → $65
Current: $52.86
Upside: +22.97%
May 8, 2026
Reiterated: Buy
Price Target: $13
Current: $5.19
Upside: +150.48%
Dec 19, 2025
Reiterated: Buy
Price Target: $10 → $4
Current: $0.368
Upside: +986.96%
Nov 11, 2024
Reiterated: Buy
Price Target: $4
Current: $5.38
Upside: n/a